Biocuration 2016 - Presentations
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Original Article Text Mining in the Biocuration Workflow: Applications for Literature Curation at Wormbase, Dictybase and TAIR
Database, Vol. 2012, Article ID bas040, doi:10.1093/database/bas040 ............................................................................................................................................................................................................................................................................................. Original article Text mining in the biocuration workflow: applications for literature curation at WormBase, dictyBase and TAIR Kimberly Van Auken1,*, Petra Fey2, Tanya Z. Berardini3, Robert Dodson2, Laurel Cooper4, Donghui Li3, Juancarlos Chan1, Yuling Li1, Siddhartha Basu2, Hans-Michael Muller1, Downloaded from Rex Chisholm2, Eva Huala3, Paul W. Sternberg1,5 and the WormBase Consortium 1Division of Biology, California Institute of Technology, 1200 E. California Boulevard, Pasadena, CA 91125, 2Northwestern University Biomedical Informatics Center and Center for Genetic Medicine, 420 E. Superior Street, Chicago, IL 60611, 3Department of Plant Biology, Carnegie Institution, 260 Panama Street, Stanford, CA 94305, 4Department of Botany and Plant Pathology, Oregon State University, Corvallis, OR 97331 and 5Howard Hughes Medical Institute, California Institute of Technology, 1200 E. California Boulevard, Pasadena, CA 91125, USA http://database.oxfordjournals.org/ *Corresponding author: Tel: +1 609 937 1635; Fax: +1 626 568 8012; Email: [email protected] Submitted 18 June 2012; Revised 30 September 2012; Accepted 2 October 2012 ............................................................................................................................................................................................................................................................................................ -
Enhanced Representation of Natural Product Metabolism in Uniprotkb
H OH metabolites OH Article Diverse Taxonomies for Diverse Chemistries: Enhanced Representation of Natural Product Metabolism in UniProtKB Marc Feuermann 1,* , Emmanuel Boutet 1,* , Anne Morgat 1 , Kristian B. Axelsen 1, Parit Bansal 1, Jerven Bolleman 1 , Edouard de Castro 1, Elisabeth Coudert 1, Elisabeth Gasteiger 1,Sébastien Géhant 1, Damien Lieberherr 1, Thierry Lombardot 1,†, Teresa B. Neto 1, Ivo Pedruzzi 1, Sylvain Poux 1, Monica Pozzato 1, Nicole Redaschi 1 , Alan Bridge 1 and on behalf of the UniProt Consortium 1,2,3,4,‡ 1 Swiss-Prot Group, SIB Swiss Institute of Bioinformatics, CMU, 1 Michel-Servet, CH-1211 Geneva 4, Switzerland; [email protected] (A.M.); [email protected] (K.B.A.); [email protected] (P.B.); [email protected] (J.B.); [email protected] (E.d.C.); [email protected] (E.C.); [email protected] (E.G.); [email protected] (S.G.); [email protected] (D.L.); [email protected] (T.L.); [email protected] (T.B.N.); [email protected] (I.P.); [email protected] (S.P.); [email protected] (M.P.); [email protected] (N.R.); [email protected] (A.B.); [email protected] (U.C.) 2 European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK 3 Protein Information Resource, University of Delaware, 15 Innovation Way, Suite 205, Newark, DE 19711, USA 4 Protein Information Resource, Georgetown University Medical Center, 3300 Whitehaven Street NorthWest, Suite 1200, Washington, DC 20007, USA * Correspondence: [email protected] (M.F.); [email protected] (E.B.); Tel.: +41-22-379-58-75 (M.F.); +41-22-379-49-10 (E.B.) † Current address: Centre Informatique, Division Calcul et Soutien à la Recherche, University of Lausanne, CH-1015 Lausanne, Switzerland. -
Research Resources for Nuclear Receptor Signaling Pathways Neil J
Molecular Pharmacology Fast Forward. Published on May 23, 2016 as DOI: 10.1124/mol.116.103713 This article has not been copyedited and formatted. The final version may differ from this version. MOL #103713 Research resources for nuclear receptor signaling pathways Neil J. McKenna Department of Molecular and Cellular Biology and Nuclear Receptor Signaling Atlas (NURSA) Bioinformatics Resource, Downloaded from Baylor College of Medicine, Houston, TX, 77030, USA molpharm.aspetjournals.org at ASPET Journals on September 27, 2021 1 Molecular Pharmacology Fast Forward. Published on May 23, 2016 as DOI: 10.1124/mol.116.103713 This article has not been copyedited and formatted. The final version may differ from this version. MOL #103713 Running title: Research resources for NR signaling pathways Corresponding author: Neil J McKenna Room M620 Baylor College of Medicine One Baylor Plaza Downloaded from Houston, TX, 77030, USA t: 713-798-7490 molpharm.aspetjournals.org f: 713-798-6822 e: [email protected] Number of text pages: 21 at ASPET Journals on September 27, 2021 Number of tables: 1 Number of figures: 1 Number of references: 56 Number of words in Abstract: 124 Review: 3613 List of non-standard abbreviations: 17βE2, 17β-estradiol; AB, Allen Brain Atlas; BG, BIOGRID; BGS, BioGPS; CoR, coregulator; CTD, Comparative Toxicogenomics Database; DAV, DAVID; DB, DrugBank; EDC, endocrine disrupting chemical; EG, Entrez Gene; EM, Edinburgh Mouse; ENC, ENCODE; ENR, ENRICHR; ENS, Ensembl; EX, Expression Atlas; GC, GeneCards; GSEA, GeneSet Enrichment Analysis; GtoP, IUPHAR Guide To Pharmacology; 2 Molecular Pharmacology Fast Forward. Published on May 23, 2016 as DOI: 10.1124/mol.116.103713 This article has not been copyedited and formatted. -
Uniprot: the Universal Protein Knowledgebase in 2021 the Uniprot Consortium1,2,3,4,*
D480–D489 Nucleic Acids Research, 2021, Vol. 49, Database issue Published online 25 November 2020 doi: 10.1093/nar/gkaa1100 UniProt: the universal protein knowledgebase in 2021 The UniProt Consortium1,2,3,4,* 1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton CB10 1SD, UK, 2Protein Information Resource, Georgetown University Medical Center, 3300 Whitehaven Street NW, Suite 1200, Washington, DC 20007, USA, 3Protein Information Resource, University of Delaware, Ammon-Pinizzotto Biopharmaceutical Innovation Building, Suite 147, 590 Avenue 1743, Newark, DE 19713, USA and 4SIB Swiss Institute of Bioinformatics, Centre Medical Universitaire, 1 rue Michel Servet, CH-1211 Geneva 4, Switzerland Received September 15, 2020; Revised October 21, 2020; Editorial Decision October 22, 2020; Accepted November 02, 2020 ABSTRACT tomated systems. The UniRef databases cluster sequence sets at various levels of sequence identity and the UniProt The aim of the UniProt Knowledgebase is to provide Archive (UniParc) delivers a complete set of known se- users with a comprehensive, high-quality and freely quences, including historical obsolete sequences. UniProt accessible set of protein sequences annotated with additionally integrates, interprets, and standardizes data functional information. In this article, we describe from multiple selected resources to add biological knowl- significant updates that we have made over the last edge and associated metadata to protein records and acts two years to the resource. The number of sequences as a central hub from which users can link out to 180 in UniProtKB has risen to approximately 190 million, other resources. In recognition of the quality of our data, despite continued work to reduce sequence redun- and the service we provide, UniProt was recognised as dancy at the proteome level. -
The Zebrafish Anatomy and Stage Ontologies: Representing the Anatomy and Development of Danio Rerio
Van Slyke et al. Journal of Biomedical Semantics 2014, 5:12 http://www.jbiomedsem.com/content/5/1/12 JOURNAL OF BIOMEDICAL SEMANTICS RESEARCH Open Access The zebrafish anatomy and stage ontologies: representing the anatomy and development of Danio rerio Ceri E Van Slyke1*†, Yvonne M Bradford1*†, Monte Westerfield1,2 and Melissa A Haendel3 Abstract Background: The Zebrafish Anatomy Ontology (ZFA) is an OBO Foundry ontology that is used in conjunction with the Zebrafish Stage Ontology (ZFS) to describe the gross and cellular anatomy and development of the zebrafish, Danio rerio, from single cell zygote to adult. The zebrafish model organism database (ZFIN) uses the ZFA and ZFS to annotate phenotype and gene expression data from the primary literature and from contributed data sets. Results: The ZFA models anatomy and development with a subclass hierarchy, a partonomy, and a developmental hierarchy and with relationships to the ZFS that define the stages during which each anatomical entity exists. The ZFA and ZFS are developed utilizing OBO Foundry principles to ensure orthogonality, accessibility, and interoperability. The ZFA has 2860 classes representing a diversity of anatomical structures from different anatomical systems and from different stages of development. Conclusions: The ZFA describes zebrafish anatomy and development semantically for the purposes of annotating gene expression and anatomical phenotypes. The ontology and the data have been used by other resources to perform cross-species queries of gene expression and phenotype data, providing insights into genetic relationships, morphological evolution, and models of human disease. Background function, development, and evolution. ZFIN, the zebrafish Zebrafish (Danio rerio) share many anatomical and physio- model organism database [10] manually curates these dis- logical characteristics with other vertebrates, including parate data obtained from the literature or by direct data humans, and have emerged as a premiere organism to submission. -
Biocuration 2016 - Posters
Biocuration 2016 - Posters Source: http://www.sib.swiss/events/biocuration2016/posters 1 RAM: A standards-based database for extracting and analyzing disease-specified concepts from the multitude of biomedical resources Jinmeng Jia and Tieliu Shi Each year, millions of people around world suffer from the consequence of the misdiagnosis and ineffective treatment of various disease, especially those intractable diseases and rare diseases. Integration of various data related to human diseases help us not only for identifying drug targets, connecting genetic variations of phenotypes and understanding molecular pathways relevant to novel treatment, but also for coupling clinical care and biomedical researches. To this end, we built the Rare disease Annotation & Medicine (RAM) standards-based database which can provide reference to map and extract disease-specified information from multitude of biomedical resources such as free text articles in MEDLINE and Electronic Medical Records (EMRs). RAM integrates disease-specified concepts from ICD-9, ICD-10, SNOMED-CT and MeSH (http://www.nlm.nih.gov/mesh/MBrowser.html) extracted from the Unified Medical Language System (UMLS) based on the UMLS Concept Unique Identifiers for each Disease Term. We also integrated phenotypes from OMIM for each disease term, which link underlying mechanisms and clinical observation. Moreover, we used disease-manifestation (D-M) pairs from existing biomedical ontologies as prior knowledge to automatically recognize D-M-specific syntactic patterns from full text articles in MEDLINE. Considering that most of the record-based disease information in public databases are textual format, we extracted disease terms and their related biomedical descriptive phrases from Online Mendelian Inheritance in Man (OMIM), National Organization for Rare Disorders (NORD) and Orphanet using UMLS Thesaurus. -
Human Disease Ontology 2018 Update: Classification, Content And
Published online 8 November 2018 Nucleic Acids Research, 2019, Vol. 47, Database issue D955–D962 doi: 10.1093/nar/gky1032 Human Disease Ontology 2018 update: classification, content and workflow expansion Lynn M. Schriml 1,*, Elvira Mitraka2, James Munro1, Becky Tauber1, Mike Schor1, Lance Nickle1, Victor Felix1, Linda Jeng3, Cynthia Bearer3, Richard Lichenstein3, Katharine Bisordi3, Nicole Campion3, Brooke Hyman3, David Kurland4, Connor Patrick Oates5, Siobhan Kibbey3, Poorna Sreekumar3, Chris Le3, Michelle Giglio1 and Carol Greene3 1University of Maryland School of Medicine, Institute for Genome Sciences, Baltimore, MD, USA, 2Dalhousie University, Halifax, NS, Canada, 3University of Maryland School of Medicine, Baltimore, MD, USA, 4New York University Langone Medical Center, Department of Neurosurgery, New York, NY, USA and 5Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA Received September 13, 2018; Revised October 04, 2018; Editorial Decision October 14, 2018; Accepted October 22, 2018 ABSTRACT INTRODUCTION The Human Disease Ontology (DO) (http://www. The rapid growth of biomedical and clinical research in re- disease-ontology.org), database has undergone sig- cent decades has begun to reveal novel cellular, molecular nificant expansion in the past three years. The DO and environmental determinants of disease (1–4). However, disease classification includes specific formal se- the opportunities for discovery and the transcendence of mantic rules to express meaningful disease mod- knowledge between research groups can only be realized in conjunction with the development of rigorous, standard- els and has expanded from a single asserted clas- ized bioinformatics tools. These tools should be capable of sification to include multiple-inferred mechanistic addressing specific biomedical data nomenclature and stan- disease classifications, thus providing novel per- dardization challenges posed by the vast variety of biomed- spectives on related diseases. -
The Chromosome-Centric Human Proteome Project for Cataloging Proteins Encoded in the Genome
CORRESPONDENCE The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome To the Editor: utility for biological and disease studies. Table 1 Features of salient genes on The Chromosome-Centric Human With development of new tools for in- chromosomes 13 and 17 Proteome Project (C-HPP) aims to define depth characterization of the transcriptome Genea AST nsSNPs the full set of proteins encoded in each and proteome, the HPP is well positioned Chromosome 13 chromosome through development of a to have a strategic role in addressing the BRCA2 3 54 standardized approach for analyzing the complexity of human phenotypes. With this RB1 2 3 massive proteomic data sets currently being in mind, the HUPO has organized national IRS2 1 3 generated from dedicated efforts of national chromosome teams that will collaborate and international teams. The initial goal with well-established laboratories building Chromosome 17 of the C-HPP is to identify at least one complementary proteotypic peptides, BRCA1 24 24 representative protein encoded by each of antibodies and informatics resources. ERBB2 6 13 the approximately 20,300 human genes1,2. An important C-HPP goal is to encourage TP53 14 5 aEnsembl protein and AST information can be found at The proteins will be characterized for tissue capture and open sharing of proteomic http://www.ensembl.org/Homo_sapiens/. localization and major isoforms, including data sets from diverse samples to enhance AST, alternative splicing transcript; nsSNP, nonsyno- mous single-nucleotide polyphorphism assembled from post-translational modifications (PTMs), a gene- and chromosome-centric display data from the 1000 Genomes Projects. -
Biocuration - Mapping Resources and Needs [Version 2; Peer Review: 2 Approved]
F1000Research 2020, 9(ELIXIR):1094 Last updated: 22 JUL 2021 RESEARCH ARTICLE Biocuration - mapping resources and needs [version 2; peer review: 2 approved] Alexandra Holinski 1, Melissa L. Burke 1, Sarah L. Morgan 1, Peter McQuilton 2, Patricia M. Palagi 3 1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridgeshire, CB10 1SD, UK 2Oxford e-Research Centre, Department of Engineering Science, University of Oxford, Oxford, Oxfordshire, OX1 3QG, UK 3SIB Swiss Institute of Bioinformatics, Lausanne, 1015, Switzerland v2 First published: 04 Sep 2020, 9(ELIXIR):1094 Open Peer Review https://doi.org/10.12688/f1000research.25413.1 Latest published: 02 Dec 2020, 9(ELIXIR):1094 https://doi.org/10.12688/f1000research.25413.2 Reviewer Status Invited Reviewers Abstract Background: Biocuration involves a variety of teams and individuals 1 2 across the globe. However, they may not self-identify as biocurators, as they may be unaware of biocuration as a career path or because version 2 biocuration is only part of their role. The lack of a clear, up-to-date (revision) report profile of biocuration creates challenges for organisations like ELIXIR, 02 Dec 2020 the ISB and GOBLET to systematically support biocurators and for biocurators themselves to develop their own careers. Therefore, the version 1 ELIXIR Training Platform launched an Implementation Study in order 04 Sep 2020 report report to i) identify communities of biocurators, ii) map the type of curation work being done, iii) assess biocuration training, and iv) draw a picture of biocuration career development. 1. Tanya Berardini , Phoenix Bioinformatics, Methods: To achieve the goals of the study, we carried out a global Fremont, USA survey on the nature of biocuration work, the tools and resources that are used, training that has been received and additional training 2. -
Improving the Gene Ontology Resource to Facilitate More Informative Analysis and Interpretation of Alzheimer’S Disease Data
G C A T T A C G G C A T genes Article Improving the Gene Ontology Resource to Facilitate More Informative Analysis and Interpretation of Alzheimer’s Disease Data Barbara Kramarz 1 , Paola Roncaglia 2 , Birgit H. M. Meldal 2 , Rachael P. Huntley 1 , Maria J. Martin 2, Sandra Orchard 2, Helen Parkinson 2, David Brough 3, Rina Bandopadhyay 4, Nigel M. Hooper 3 and Ruth C. Lovering 1,* 1 UCL Institute of Cardiovascular Science, University College London, Rayne Building, 5 University Street, London WC1E 6JF, UK; [email protected] (B.K.); [email protected] (R.P.H.) 2 European Bioinformatics Institute (EMBL-EBI), European Molecular Biology Laboratory, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK; [email protected] (P.R.); [email protected] (B.H.M.M.); [email protected] (M.J.M.); [email protected] (S.O.); [email protected] (H.P.) 3 Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, AV Hill Building, Oxford Road, Manchester M13 9PT, UK; [email protected] (D.B.); [email protected] (N.M.H.) 4 UCL Queen Square Institute of Neurology and Reta Lila Weston Institute of Neurological Studies, 1 Wakefield Street, London WC1N 1PJ, UK; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +44-207-679-6965 Received: 31 October 2018; Accepted: 23 November 2018; Published: 29 November 2018 Abstract: The analysis and interpretation of high-throughput datasets relies on access to high-quality bioinformatics resources, as well as processing pipelines and analysis tools. -
Biocuration Experts on the Impact of Duplication and Other Data Quality Issues in Biological Databases
Genomics Proteomics Bioinformatics 18 (2020) 91–103 Genomics Proteomics Bioinformatics www.elsevier.com/locate/gpb www.sciencedirect.com PERSPECTIVE Quality Matters: Biocuration Experts on the Impact of Duplication and Other Data Quality Issues in Biological Databases Qingyu Chen 1,*, Ramona Britto 2, Ivan Erill 3, Constance J. Jeffery 4, Arthur Liberzon 5, Michele Magrane 2, Jun-ichi Onami 6,7, Marc Robinson-Rechavi 8,9, Jana Sponarova 10, Justin Zobel 1,*, Karin Verspoor 1,* 1 School of Computing and Information Systems, University of Melbourne, Melbourne, VIC 3010, Australia 2 European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Cambridge CB10 1SD, UK 3 Department of Biological Sciences, University of Maryland, Baltimore, MD 21250, USA 4 Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA 5 Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA 6 Japan Science and Technology Agency, National Bioscience Database Center, Tokyo 102-8666, Japan 7 National Institute of Health Sciences, Tokyo 158-8501, Japan 8 Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland 9 Department of Ecology and Evolution, University of Lausanne, CH-1015 Lausanne, Switzerland 10 Nebion AG, 8048 Zurich, Switzerland Received 8 December 2017; revised 24 October 2018; accepted 14 December 2018 Available online 9 July 2020 Handled by Zhang Zhang Introduction assembled, annotated, and ultimately submitted to primary nucleotide databases such as GenBank [2], European Nucleo- tide Archive (ENA) [3], and DNA Data Bank of Japan Biological databases represent an extraordinary collective vol- (DDBJ) [4] (collectively known as the International Nucleotide ume of work. -
The Evaluation of Ontologies: Editorial Review Vs
The Evaluation of Ontologies: Editorial Review vs. Democratic Ranking Barry Smith Department of Philosophy, Center of Excellence in Bioinformatics and Life Sciences, and National Center for Biomedical Ontology University at Buffalo from Proceedings of InterOntology 2008 (Tokyo, Japan, 26-27 February 2008), 127-138. ABSTRACT. Increasingly, the high throughput technologies used by biomedical researchers are bringing about a situation in which large bodies of data are being described using controlled structured vocabularies—also known as ontologies—in order to support the integration and analysis of this data. Annotation of data by means of ontologies is already contributing in significant ways to the cumulation of scientific knowledge and, prospectively, to the applicability of cross-domain algorithmic reasoning in support of scientific advance. This very success, however, has led to a proliferation of ontologies of varying scope and quality. We define one strategy for achieving quality assurance of ontologies—a plan of action already adopted by a large community of collaborating ontologists—which consists in subjecting ontologies to a process of peer review analogous to that which is applied to scientific journal articles. 1 From OBO to the OBO Foundry Our topic here is the use of ontologies to support scientific research, especially in the domains of biology and biomedicine. In 2001, Open Biomedical Ontologies (OBO) was created by Michael Ashburner and Suzanna Lewis as an umbrella body for the developers of such ontologies in the domain of the life sciences, applying the key principles underlying the success of the Gene Ontology (GO) [GOC 2006], namely, that ontologies be (a) open, (b) orthogonal, (c) instantiated in a well-specified syntax, and such as (d) to share a common space of identifiers [Ashburner et al.